Should procalcitonin be measured routinely in acute decompensated heart failure?

被引:4
|
作者
Loncar, Goran [1 ]
Tscholl, Verena [2 ]
Tahirovic, Elvis [2 ]
Sekularac, Nikola [1 ]
Marx, Almuth [3 ]
Obradovic, Danilo [2 ]
Veskovic, Jovan [2 ]
Lainscak, Mitja [4 ,5 ,6 ]
von Haehling, Stephan [7 ,8 ]
Edelmann, Frank [2 ]
Arandjelovic, Aleksandra [1 ,9 ]
Apostolovic, Svetlana [10 ]
Stanojevic, Dragana [10 ]
Pieske, Burkert [2 ]
Trippel, Tobias [2 ]
Dungen, Hans-Dirk [2 ]
机构
[1] Clin Hosp Zvezdara, Dept Cardiol, Belgrade, Serbia
[2] Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Marx Stat, Nurnberg, Germany
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Gen Hosp Celje, Dept Res & Educ, Celje, Slovenia
[6] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[7] Charite, Appl Cachexia Res, Dept Cardiol, Berlin, Germany
[8] Charite, CCR, Berlin, Germany
[9] Univ Belgrade, Sch Med, Belgrade 11001, Serbia
[10] Clin Ctr Nis, Clin Cardiovasc Dis, Nish, Serbia
关键词
ADHF; NT-proBNP; procalcitonin; prognosis; serial measurements; CRITICALLY-ILL PATIENTS; NATRIURETIC PEPTIDE; IMMUNE ACTIVATION; CARDIOGENIC-SHOCK; DIAGNOSIS; BIOMARKERS; MORTALITY; INFECTION; ENDOTOXIN; INCREASE;
D O I
10.2217/BMM.15.29
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: To elucidate the prognostic role of procalcitonin (PCT) in patients with acute decompensated heart failure (ADHF) without clinical signs of infection at admission. Materials & Methods: Serial measurements of PCT and NT-proBNP were performed in 168 patients, aged 68 +/- 10 years with ADHF followed by 3-month outcome evaluation. Results: Cox regression analysis demonstrated significant predictive value of baseline PCT for all-cause death/hospitalization (area under the curve: 0.67; p = 0.013) at 90th day. The patients with persistently elevated PCT or with an increase during the first 72 h of hospitalization had the worst prognosis (p = 0.0002). Conclusion: Baseline and serial in-hospital measurements of PCT have significant prognostic properties for 3-month all-cause mortality/hospitalization in patients with ADHF without clinical signs of infection at admission.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 50 条
  • [41] Acute Decompensated Heart Failure Is There a Path Forward?
    O'Connor, Christopher M.
    JACC-HEART FAILURE, 2019, 7 (10) : 911 - 912
  • [42] Mitral Regurgitation in Acute Decompensated Heart Failure
    Mehmood, Muddassir
    JACC-HEART FAILURE, 2021, 9 (04) : 321 - 322
  • [43] Pulmonary ultrasonography in acute decompensated heart failure
    Faistauer, Angela
    Gheller, Ana
    Nicolaidis, Rafael
    Danzmann, Luiz Claudio
    SCIENTIA MEDICA, 2010, 20 (02) : 194 - 199
  • [44] Acute Decompensated Heart Failure, Volume, and Acetazolamide
    Culic, Viktor
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (26): : 2485 - 2487
  • [45] New therapies in acute decompensated heart failure
    Gauthier, Nadine
    Anselm, Anjali H.
    Haddad, Haissam
    CURRENT OPINION IN CARDIOLOGY, 2008, 23 (02) : 134 - 140
  • [46] Update on the management of acute decompensated heart failure
    Majure D.T.
    Teerlink J.R.
    Current Treatment Options in Cardiovascular Medicine, 2011, 13 (6) : 570 - 585
  • [47] From Acute Decompensated to Chronic Heart Failure
    Patel, Snehal R.
    Pina, Ileana L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (12): : 1923 - 1929
  • [48] Iron Deficiency in Acute Decompensated Heart Failure
    Beale, Anna
    Carballo, Davis
    Stirnemann, Jerome
    Garin, Nicolas
    Agoritsas, Thomas
    Serratrice, Jacques
    Kaye, David
    Meyer, Philippe
    Carballo, Sebastian
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [49] Diuretics for the treatment of acute decompensated heart failure
    Iyengar, Srinivas
    Abraham, William T.
    HEART FAILURE REVIEWS, 2007, 12 (02) : 125 - 130
  • [50] Ivabradine in acute decompensated systolic heart failure
    Sargento, Luis
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 235 : 197 - 197